2nd International Conference on MXenes, Beijing, China on May 10-12, 2019
www.MXenes2019.org
2nd International Conference on MXenes will be held in Beijing, China on May 10-12, 2019. The conference is hosted and organized by Beijing University of Chemical Technology.
Two-dimensional (2D) materials became the focus of material research in the past decade owing to their unique chemical, electronic, optical, mechanical, and thermal properties that are different from their bulk counterparts. These unique properties are, in part, the result of quantum confinement effect in the atomically-thin 2D layers and are strongly dependent on the layer thickness and composition. Moreover, the properties of 2D materials are highly tunable by chemical doping, strain engineering, and external fields. 
 While graphene is still remaining the most widely researched 2D material, the discovery of 2D titanium carbide (Ti3C2) by Drexel University researchers in 2011 added a new family of materials known as MXenes to the 2D world. In general, the term MXenes refers to a very large family of 2D transition metal carbides, carbonitrides, and nitrides with the formula Mn+1XnTx, where M represents an early transition metal, X is carbon and/or nitrogen, and T stands for surface termination (such as OH, O, Cl, or F). 
 Research on MXenes is ongoing in more than 40 countries, with China leading in the number of publications. Therefore, it’s not surprising that the 1st International Conference on MXenes for Energy was organized at Jilin University in 2018. It attracted about 200 researchers. The 2nd International Conference on MXenes is expected to have twice the number of attendees and will also cover all areas of applications of MXenes, including but not limited to energy storage and generation, electromagnetic interference shielding, antennas, transparent conductors, gas and pressure sensors, water purification, gas separation membranes, photo- and electrocatalysis, medicine and plasmonics. Due to a large variety of transition metals and surface functionalities, MXenes’ properties can be tuned by selecting combinations of transition metals, X elements, and controlling their surface chemistries. There are endless and quickly expanding opportunities for producing MXenes with desirable properties.

 Leading Chinese and foreign researchers working on MXenes will be giving plenary and invited talks at the conference. We hope that this conference will provide a forum for scientists from all over the world, both theorists and experimentalists, to meet and share information about synthesis, fundamental properties and applications of this quickly expanding family of 2D materials.
Conference co-chairs Prof. Bin Xu (Beijing University of Chemical Technology) and Prof. Yury Gogotsi (Drexel University and Jilin University) are looking forward to seeing you in Beijing!
Read more about the conference on www.MXenes2019.org

 
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year!  Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics.  Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about  MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
